Related Experiment Video
Updated: Jul 11, 2026
The Intra-Aortic Balloon Pump
Published on: February 5, 2021
Long intraaortic balloon treatment time leads to more vascular complications
Jan T Christenson1, Jorge Sierra, Jacques-André Romand
1Department of Cardiovascular Surgery, University Hospital of Geneva, 24 rue Micheli-du-Crest, CH-1211 Geneva 14, Switzerland. jan.christenson@hcuge.ch
Insights
Intra-aortic balloon pump therapy is effective but prolonged use increases limb ischemia risk. Treatment duration is a key factor in complications, with longer times linked to higher rates.
Area of Science:
- Cardiovascular Medicine
- Medical Devices
- Interventional Cardiology
Background:
- Intra-aortic balloon counterpulsation (IABP) is a widely used circulatory support therapy.
- Limb ischemia is a significant complication associated with IABP use.
Purpose of the Study:
- To retrospectively analyze the impact of intra-aortic balloon counterpulsation treatment duration on balloon-related complications.
- To identify risk factors associated with intra-aortic balloon counterpulsation complications.
Main Methods:
- Retrospective analysis of 135 patients undergoing intra-aortic balloon counterpulsation between 1998 and 2004.
- Categorization of patients based on clinical indication: high-risk coronary, cardiogenic shock, or weaning from cardiopulmonary bypass.
- Comparison of treatment durations and complication rates between patient groups.
Main Results:
- Overall complication rate was 14.8% (20/135), with limb ischemia in 13.3% (18/135).
- Patients developing limb ischemia had significantly longer treatment times (99.8 ± 54.1 h) versus those without (34.4 ± 30.4 h).
- Independent risk factors for complications included long treatment time, acute myocardial infarction, age >65, and ejection fraction <0.30.
Conclusions:
- Intra-aortic balloon pumping offers effective circulatory support with a generally low complication rate.
- Treatment duration is a critical factor influencing the incidence of balloon-related complications, particularly limb ischemia.
- Identifying patients with risk factors like advanced age and low ejection fraction is crucial for managing IABP therapy.
Abstract:
Intraaortic balloon counterpulsation is an established and efficient therapy. Limb ischemia is the most common complication. The impact of treatment duration on balloon-related complications was analyzed retrospectively in 135 patients who underwent balloon counterpulsation between 1998 and 2004. Thirty high-risk coronary patients required preoperative intraaortic balloon therapy, 41 were in preoperative cardiogenic shock, and 64 needed support for difficulties in weaning from cardiopulmonary bypass. No balloon-related mortality occurred. The overall balloon-related complication rate was 20/135 (14.8%); 18 had limb ischemia, of whom 6 (4.4%) required vascular interventions. Intraaortic balloon treatment time was significantly longer in patients who developed limb ischemia (99.8 +/- 54.1 h) compared to those who did not (34.4 +/- 30.4 h). Preoperative therapy had short treatment times and few complications. Intraaortic balloon pumping provides effective circulatory support with a low complication rate. A clear relationship was established between duration of treatment and balloon-related complications. Independent risk factors for balloon-related complications were long treatment time, acute myocardial infarction, age over 65 years, and ejection fraction less than 0.30.
